The two pharmaceutical companies are facing a legal battle after Mylan filed a new drug application for a generic of Novo Nordisk’s Victoza.
List view / Grid view
Filter the results
New research has found that of the 38 warning letters handed out by the FDA in 2019, the US and India received the vast majority.
The US District Court has decided in favour of Amgen’s Enbrel, ruling over Sandoz’s Erelzi in a patent conflict.
Pharma contract placement was found to increase by 250 percent compared to last year, according to figures from a recruitment firm.
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
The CMA alleges that a pharmaceutical company agreed to buy equal quantities of a pill from two drug suppliers, breaking competition law.
Two pharmaceutical companies have partnered to develop a slow-release drug to treat patients with HIV.
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.